MedElevator Войти в исследования
← Поиск публикаций

DOI 10.21873/anticanres.14055

Медицинская библиотека · Anticancer research · 2020

The Efficacy of Second-line Chemotherapy for Advanced or Metastatic Urothelial Cancer.

Naito Renato, Izumi Kouji, Kadomoto Suguru, Makino Tomoyuki, Iwamoto Hiroaki, Yaegashi Hiroshi, Shigehara Kazuyoshi, Kadono Yoshifumi, Mizokami Atsushi

СтатьяПеревод в очереди

Аннотация

BACKGROUND/AIM: This study aimed to assess the efficacy and toxicity of second-line chemotherapy, especially combination chemotherapy, for advanced or metastatic urothelial cancer.

PATIENTS AND

METHODS

This retrospective analysis included patients who received second-line chemotherapy after disease progression during first-line chemotherapy between January 2009 to May 2018. Progression-free survival (PFS), overall survival (OS) and toxicity associated with second-line chemotherapy were assessed.

RESULTS

In total 25 patients received second-line chemotherapy; 21 patients had combination chemotherapy and 4 had single-agent chemotherapy. Median PFS and OS were 3.6 months (range=0.2-23.5) and 11.9 months (range=0.5-29.0), respectively. Twenty patients (80%) exhibited grade 3 or more severe toxicities.

CONCLUSION

PFS and OS benefits of second-line combination chemotherapy corresponded to those of the phase 3 study of pembrolizumab, but adverse events were more severe. Pembrolizumab is potentially a better second-line treatment than combination chemotherapy.

Для цитирования: Naito Renato, Izumi Kouji, Kadomoto Suguru, Makino Tomoyuki, Iwamoto Hiroaki, Yaegashi Hiroshi, Shigehara Kazuyoshi, Kadono Yoshifumi, Mizokami Atsushi. The Efficacy of Second-line Chemotherapy for Advanced or Metastatic Urothelial Cancer.. Anticancer research. 2020. DOI: 10.21873/anticanres.14055.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.